These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1173 related items for PubMed ID: 11869666

  • 21. Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.
    Giaquinto C, Rampon O, De Rossi A.
    Clin Drug Investig; 2006; 26(11):611-27. PubMed ID: 17163296
    [Abstract] [Full Text] [Related]

  • 22. A randomized, double-blind, placebo-controlled trial of combined nevirapine and zidovudine compared with nevirapine alone in the prevention of perinatal transmission of HIV in Zimbabwe.
    Thistle P, Spitzer RF, Glazier RH, Pilon R, Arbess G, Simor A, Boyle E, Chitsike I, Chipato T, Gottesman M, Silverman M.
    Clin Infect Dis; 2007 Jan 01; 44(1):111-9. PubMed ID: 17143826
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    Ugwu EO, Eleje GU, Ugwu AO, Nwagha UI, Ikechebelu JI, Umeh UA, Okafor HU.
    Cochrane Database Syst Rev; 2023 Jun 12; 6(6):CD013653. PubMed ID: 37306558
    [Abstract] [Full Text] [Related]

  • 25. Field efficacy of zidovudine, lamivudine and single-dose nevirapine to prevent peripartum HIV transmission.
    Dabis F, Bequet L, Ekouevi DK, Viho I, Rouet F, Horo A, Sakarovitch C, Becquet R, Fassinou P, Dequae-Merchadou L, Welffens-Ekra C, Rouzioux C, Leroy V, ANRS 1201/1202 DITRAME PLUS Study Group.
    AIDS; 2005 Feb 18; 19(3):309-18. PubMed ID: 15718842
    [Abstract] [Full Text] [Related]

  • 26. Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection.
    Bhana N, Ormrod D, Perry CM, Figgitt DP.
    Paediatr Drugs; 2002 Feb 18; 4(8):515-53. PubMed ID: 12126455
    [Abstract] [Full Text] [Related]

  • 27. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE, Kumwenda NI, Hoover DR, Fiscus SA, Kafulafula G, Nkhoma C, Nour S, Chen S, Liomba G, Miotti PG, Broadhead RL.
    JAMA; 2004 Jul 14; 292(2):202-9. PubMed ID: 15249569
    [Abstract] [Full Text] [Related]

  • 28. Comparison of safety and effectiveness of antiretroviral therapy regimens among pregnant women living with HIV at preconception or during pregnancy: a systematic review and network meta-analysis of randomized trials.
    Mehrabi F, Karamouzian M, Farhoudi B, Moradi Falah Langeroodi S, Mehmandoost S, Abbaszadeh S, Motaghi S, Mirzazadeh A, Sadeghirad B, Sharifi H.
    BMC Infect Dis; 2024 Apr 19; 24(1):417. PubMed ID: 38641597
    [Abstract] [Full Text] [Related]

  • 29. Progress in reducing mother-to-infant HIV transmission.
    Jackson B.
    Hopkins HIV Rep; 1999 May 19; 11(3):2, 11. PubMed ID: 11367370
    [Abstract] [Full Text] [Related]

  • 30. Vitamin A supplements for reducing mother-to-child HIV transmission.
    Wiysonge CS, Ndze VN, Kongnyuy EJ, Shey MS.
    Cochrane Database Syst Rev; 2017 Sep 07; 9(9):CD003648. PubMed ID: 28880995
    [Abstract] [Full Text] [Related]

  • 31. Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.
    Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.
    Clin Infect Dis; 2008 Feb 15; 46(4):611-21. PubMed ID: 18197758
    [Abstract] [Full Text] [Related]

  • 32. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection.
    Bardsley-Elliot A, Perry CM.
    Paediatr Drugs; 2000 Feb 15; 2(5):373-407. PubMed ID: 11022799
    [Abstract] [Full Text] [Related]

  • 33. Strategies to prevent mother-to-child transmission of HIV.
    McIntyre J.
    Curr Opin Infect Dis; 2006 Feb 15; 19(1):33-8. PubMed ID: 16374215
    [Abstract] [Full Text] [Related]

  • 34. Antiretroviral treatment and prevention of peripartum and postnatal HIV transmission in West Africa: evaluation of a two-tiered approach.
    Tonwe-Gold B, Ekouevi DK, Viho I, Amani-Bosse C, Toure S, Coffie PA, Rouet F, Becquet R, Leroy V, El-Sadr WM, Abrams EJ, Dabis F.
    PLoS Med; 2007 Aug 15; 4(8):e257. PubMed ID: 17713983
    [Abstract] [Full Text] [Related]

  • 35. Single-dose perinatal nevirapine plus standard zidovudine to prevent mother-to-child transmission of HIV-1 in Thailand.
    Lallemant M, Jourdain G, Le Coeur S, Mary JY, Ngo-Giang-Huong N, Koetsawang S, Kanshana S, McIntosh K, Thaineua V, Perinatal HIV Prevention Trial (Thailand) Investigators.
    N Engl J Med; 2004 Jul 15; 351(3):217-28. PubMed ID: 15247338
    [Abstract] [Full Text] [Related]

  • 36. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H, Mofenson LM, Ekpini R, Gilks CF, Barnhart M, Bolu O, Shaffer N.
    Am J Obstet Gynecol; 2007 Sep 15; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [Abstract] [Full Text] [Related]

  • 37. A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
    Samuel R, Paredes R, Parboosing R, Moodley P, Singh L, Naidoo A, Gordon M.
    J Med Virol; 2015 Oct 15; 87(10):1662-7. PubMed ID: 25940687
    [Abstract] [Full Text] [Related]

  • 38. Global strategies for the prevention of HIV transmission from mothers to infants: the second conference.
    MacDougall DS.
    J Int Assoc Physicians AIDS Care; 1999 Dec 15; 5(12):52-7, 62. PubMed ID: 11367349
    [Abstract] [Full Text] [Related]

  • 39. Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
    Jamieson DJ, Chasela CS, Hudgens MG, King CC, Kourtis AP, Kayira D, Hosseinipour MC, Kamwendo DD, Ellington SR, Wiener JB, Fiscus SA, Tegha G, Mofolo IA, Sichali DS, Adair LS, Knight RJ, Martinson F, Kacheche Z, Soko A, Hoffman I, van der Horst C, BAN study team.
    Lancet; 2012 Jun 30; 379(9835):2449-2458. PubMed ID: 22541418
    [Abstract] [Full Text] [Related]

  • 40. The impact of maternal highly active antiretroviral therapy and short-course combination antiretrovirals for prevention of mother-to-child transmission on early infant infection rates at the Mulago national referral hospital in Kampala, Uganda, January 2007 to May 2009.
    Namukwaya Z, Mudiope P, Kekitiinwa A, Musoke P, Matovu J, Kayma S, Salmond W, Bitarakwate E, Mubiru M, Maganda A, Galla M, Byamugisha J, Fowler MG.
    J Acquir Immune Defic Syndr; 2011 Jan 01; 56(1):69-75. PubMed ID: 21099692
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 59.